Trial Profile
Phase I/II first-in-human study of APB-101
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 28 Aug 2017
Price :
$35
*
At a glance
- Drugs APB-101 (Primary)
- Indications Alpha 1-antitrypsin deficiency
- Focus Adverse reactions; First in man; Therapeutic Use
- 28 Aug 2017 New trial record